Surendra Shukla to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Surendra Shukla has written about Xenograft Model Antitumor Assays.
Connection Strength
1.166
-
Molecular and Physiological Evaluation of Pancreatic Cancer-Induced Cachexia. Methods Mol Biol. 2019; 1882:321-333.
Score: 0.585
-
Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth. Oncotarget. 2015 Dec 01; 6(38):41146-61.
Score: 0.472
-
Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. Gastroenterology. 2021 11; 161(5):1584-1600.
Score: 0.043
-
De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer. Cancer Res. 2017 10 15; 77(20):5503-5517.
Score: 0.033
-
MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer. Clin Cancer Res. 2017 Oct 01; 23(19):5881-5891.
Score: 0.033